Masivet 150mg for dogs Pack of 30 tablets

£169.16

Masivet is a cancer treatment for dogs specifically canine mast cell tumour (cancer).

Legal category: POM-V

This product requires a veterinary prescription for purchase.

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

Delivery & Returns

Secure Checkout with

Accredited Retailer

Masivet is the first drug registered against cancer in the history of veterinary medicine. Masivet is a tyrosine kinase inhibitor able to target selectively tumour cells.

Masivet^® is prescribed for the treatment of non-resectable (inoperable) high grade mast cell tumours - Patnaik grade 2 and grade 3.

Masivet^® is not a cytotoxic chemotherapy. It is a highly targeted treatment designed to work specifically and selectively on key biological pathways that cause the growth and spread of mast cell tumours.

Masivet^® is an effective, well-tolerated and proven treatment - and it was the first cancer medicine in the UK to be approved and licensed by the Veterinary Medicines Directorate for the treatment of dogs.

Masivet^® acts systemically and has been shown in clinical studies to induce tumour shrinkage and to significantly prolong time to MCT progression.

Product Description

Masivet is the first drug registered against cancer in the history of veterinary medicine. Masivet is a tyrosine kinase inhibitor able to target selectively tumour cells.

Masivet^® is prescribed for the treatment of non-resectable (inoperable) high grade mast cell tumours – Patnaik grade 2 and grade 3.

Masivet^® is not a cytotoxic chemotherapy. It is a highly targeted treatment designed to work specifically and selectively on key biological pathways that cause the growth and spread of mast cell tumours.

Masivet^® is an effective, well-tolerated and proven treatment – and it was the first cancer medicine in the UK to be approved and licensed by the Veterinary Medicines Directorate for the treatment of dogs.

Masivet^® acts systemically and has been shown in clinical studies to induce tumour shrinkage and to significantly prolong time to MCT progression.